Family Med Medical News about drug treatment

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length
Journal of Clinical Epidemiology, 11/05/09

Gardarsdottir H et al. – Differences in median episode length exist between methods that account for or disregard prescription overlap. These differences are of importance for studies that focus on drug exposure–outcome relationships and could have consequences for epidemiological analysis.

<< Previous
ALX4 dysfunction disrupts craniofacial and epidermal development

Next >>
Real-world effectiveness of new medicines should be evaluated by...

Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09 Relevance Score: 70%

Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis
Respiratory Medicine, 11/11/09 Relevance Score: 69%

Vertex drug helps hepatitis C patients
Internet Source, 11/05/09 Relevance Score: 68%

Vertex drug helps hepatitis C patients
Internet Source, 10/29/09 Relevance Score: 68%

Drug Combo May Offer Best Relief for Nerve Pain
MedLinePlus, 10/01/09 Relevance Score: 68%